To protect peripheral oxaliplatin-related neuralgia by pregabalin in Kansai area - To protect peripheral oxaliplatin-related neuralgia by pregabalin in Kansai area : HARUKA study

Osaka City University Graduate School of Medicine Department of Surgical Oncology0 个研究点目标入组 120 人开始时间: 2013年4月8日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)transfusion, G-CSF etc. within 7days 2)severe allergic reaction 3)peripheral neuropthy 4)Simultaneous or metachronous double cancers 5)Active infectious disease 6)Severe mental disease 7)Grade2+, diarrhea 8)systemic administration of corticosteroids 9)Pregnant or lactating women or women of childbearing potential 10)Severe comorbidity (interstitial peumonitis, lung fibrosis, paralytic ileus, mechanical ileus, uncontrollable diabetes, liver cirosis, chronic hepatitis, career with hepatitis B/C, renal failure, heart failure, uncontrollable hypertension, unstable angina etc) 11)AMI within 6 months 12)History of transplantation 13)Preoperative therapy for CRC 14)History of colostomy 15)Unhealing of post-operative complication 16)Gashajinkigan, or drug for neuropathy 17)Any other cases who are regarded as inadequate for study enrollment by the investigator

发起方

Osaka City University Graduate School of Medicine Department of Surgical Oncology